CPIX (STOCKS)
Cumberland Pharmaceuticals Inc
$5.600000
+0.000000 (+0.00%)
Prev close: $5.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- A. J. Kazimi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $84.65M
- Employees
- 91
- P/E (TTM)
- -11.35
- P/B (TTM)
- 3.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $41.94M |
| Benefits Costs and Expenses | $49.19M |
| Cost Of Revenue | $7.18M |
| Costs And Expenses | $49.21M |
| Gross Profit | $34.76M |
| Operating Expenses | $47.22M |
| Research and Development | $5.73M |
| Other Operating Expenses | $36.25M |
| Operating Income/Loss | -$7.21M |
| Income/Loss Before Equity Method Investments | -$7.20M |
| Income/Loss From Continuing Operations After Tax | -$7.25M |
| Income/Loss From Continuing Operations Before Tax | -$7.24M |
| Income/Loss From Equity Method Investments | -$159.30K |
| Income Tax Expense/Benefit | $38.46K |
| Interest Expense, Operating | $418.03K |
| Net Income/Loss | -$7.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$17.11K |
| Net Income/Loss Attributable To Parent | -$7.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.49 |
| Diluted Earnings Per Share | -$0.49 |
| Basic Average Shares | 44,780,015 |
| Diluted Average Shares | 44,780,015 |
| Assets | $71.00M |
| Current Assets | $32.79M |
| Inventory | $5.45M |
| Other Current Assets | $27.34M |
| Noncurrent Assets | $38.21M |
| Fixed Assets | $237.38K |
| Other Non-current Assets | $37.97M |
| Liabilities | $49.69M |
| Current Liabilities | $34.49M |
| Accounts Payable | $16.54M |
| Other Current Liabilities | $17.95M |
| Noncurrent Liabilities | $15.20M |
| Equity | $21.30M |
| Equity Attributable To Noncontrolling Interest | -$333.51K |
| Equity Attributable To Parent | $21.64M |
| Liabilities And Equity | $71.00M |
| Net Cash Flow From Operating Activities | $1.42M |
| Net Cash Flow From Operating Activities, Continuing | $1.42M |
| Net Cash Flow From Investing Activities | -$3.54M |
| Net Cash Flow From Investing Activities, Continuing | -$3.54M |
| Net Cash Flow From Financing Activities | -$1.98M |
| Net Cash Flow From Financing Activities, Continuing | -$1.98M |
| Net Cash Flow | -$4.10M |
| Net Cash Flow, Continuing | -$4.10M |
| Comprehensive Income/Loss | -$7.40M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.40M |
| Other Comprehensive Income/Loss | $0.00 |